Merck, Bristol Myers Cancer Drugs Included in September FDA Advisory Panel Meeting
Bristol-Myers Squibb Company's (NYSE:BMY) Latest 3.0% Decline Adds to One-year Losses, Institutional Investors May Consider Drastic Measures
Express News | Bristol-Myers Squibb Says FDA Schedules Oncologic Drugs Advisory Committee Meeting For September 26 To Discuss PD-L1 Expression Levels In Gastric And Esophageal Cancers
Express News | Bristol-Myers Squibb Co - Meeting to Discuss Pd-L1 Expression Levels in Gastric and Esophageal Cancers
Express News | Bristol-Myers Squibb Co - FDA Will Hold a Public Meeting of the Oncologic Drugs Advisory Committee (Odac) on September 26
Express News | Zenas Biopharma Inc Says Bristol-Myers Squibb Co, Xencor Inc Are Among 5% or Greater Stockholders in the Company
